-
Fund Dashboard
- Holdings
BlackRock Future Health ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
BlackRock Cash Funds: Institutional, SL Agency Shares | 270.51 k | 270.40 k shares | 6.49 | Short-term investment vehicle | Long | USA |
BlackRock Cash Funds: Treasury, SL Agency Shares | 270.00 k | 270.00 k shares | 6.48 | Short-term investment vehicle | Long | USA |
BSX Boston Scientific Corporation | 150.57 k | 2.04 k shares | 3.61 | Common equity | Long | USA |
COR Cencora | 144.87 k | 609.00 shares | 3.48 | Common equity | Long | USA |
ISRG Intuitive Surgical, Inc. | 117.38 k | 264.00 shares | 2.82 | Common equity | Long | USA |
ARGX argenx SE | 111.43 k | 216.00 shares | 2.68 | Common equity | Long | Netherlands |
ALNY Alnylam Pharmaceuticals, Inc. | 108.04 k | 455.00 shares | 2.59 | Common equity | Long | USA |
MTD Mettler-Toledo International Inc. | 104.95 k | 69.00 shares | 2.52 | Common equity | Long | USA |
WST West Pharmaceutical Services, Inc. | 103.18 k | 337.00 shares | 2.48 | Common equity | Long | USA |
AMGN Amgen Inc. | 101.07 k | 304.00 shares | 2.43 | Common equity | Long | USA |
DHR Danaher Corporation | 84.79 k | 306.00 shares | 2.04 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 78.93 k | 936.00 shares | 1.90 | Common equity | Long | USA |
TECH Bio-Techne Corporation | 78.57 k | 963.00 shares | 1.89 | Common equity | Long | USA |
UNH UnitedHealth Group Incorporated | 74.32 k | 129.00 shares | 1.78 | Common equity | Long | USA |
QIAGEN NV
|
74.16 k | 1.67 k shares | 1.78 | Common equity | Long | Netherlands |
MCK McKesson Corporation | 71.57 k | 116.00 shares | 1.72 | Common equity | Long | USA |
WAT Waters Corporation | 69.27 k | 206.00 shares | 1.66 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 67.47 k | 110.00 shares | 1.62 | Common equity | Long | USA |
SYK Stryker Corporation | 62.87 k | 192.00 shares | 1.51 | Common equity | Long | USA |
Gerresheimer AG
|
59.14 k | 572.00 shares | 1.42 | Common equity | Long | Germany |
ALGN Align Technology, Inc. | 57.51 k | 248.00 shares | 1.38 | Common equity | Long | USA |
MASI Masimo Corporation | 57.34 k | 536.00 shares | 1.38 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 55.88 k | 1.16 k shares | 1.34 | Common equity | Long | USA |
MOH Molina Healthcare, Inc. | 54.94 k | 161.00 shares | 1.32 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 50.97 k | 360.00 shares | 1.22 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 49.78 k | 631.00 shares | 1.20 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 49.51 k | 878.00 shares | 1.19 | Common equity | Long | Cayman Islands |
SRPT Sarepta Therapeutics, Inc. | 49.36 k | 347.00 shares | 1.19 | Common equity | Long | USA |
BIIB Biogen Inc. | 47.97 k | 225.00 shares | 1.15 | Common equity | Long | USA |
Zealand Pharma A/S
|
47.56 k | 353.00 shares | 1.14 | Common equity | Long | Denmark |
EW Edwards Lifesciences Corporation | 45.96 k | 729.00 shares | 1.10 | Common equity | Long | USA |
INSM Insmed Incorporated | 45.03 k | 619.00 shares | 1.08 | Common equity | Long | USA |
Merus NV
|
44.24 k | 834.00 shares | 1.06 | Common equity | Long | Netherlands |
COO The Cooper Companies, Inc. | 43.49 k | 466.00 shares | 1.04 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc. | 42.70 k | 990.00 shares | 1.03 | Common equity | Long | Canada |
UTHR United Therapeutics Corporation | 42.61 k | 136.00 shares | 1.02 | Common equity | Long | USA |
ELV Elevance Health Inc. | 42.03 k | 79.00 shares | 1.01 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 38.66 k | 357.00 shares | 0.93 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 38.37 k | 480.00 shares | 0.92 | Common equity | Long | USA |
RGEN Repligen Corporation | 35.81 k | 214.00 shares | 0.86 | Common equity | Long | USA |
CRL Charles River Laboratories International, Inc. | 35.64 k | 146.00 shares | 0.86 | Common equity | Long | USA |
AstraZeneca PLC
|
34.75 k | 439.00 shares | 0.83 | Common equity | Long | UK |
Lonza Group AG
|
34.63 k | 52.00 shares | 0.83 | Common equity | Long | Switzerland |
HOLX Hologic, Inc. | 33.30 k | 408.00 shares | 0.80 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 32.54 k | 869.00 shares | 0.78 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 32.13 k | 704.00 shares | 0.77 | Common equity | Long | USA |
SNY Sanofi | 31.35 k | 605.00 shares | 0.75 | Common equity | Long | France |
LH Laboratory Corporation of America Holdings | 30.59 k | 142.00 shares | 0.73 | Common equity | Long | USA |
BGNE BeiGene, Ltd. | 30.15 k | 181.00 shares | 0.72 | Common equity | Long | Cayman Islands |
Sartorius AG | 29.50 k | 104.00 shares | 0.71 | Preferred equity | Long | Germany |
GH Guardant Health, Inc. | 27.96 k | 796.00 shares | 0.67 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 26.68 k | 672.00 shares | 0.64 | Common equity | Long | UK |
INSP Inspire Medical Systems, Inc. | 25.95 k | 184.00 shares | 0.62 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 25.65 k | 1.09 k shares | 0.62 | Common equity | Long | USA |
ConvaTec Group PLC
|
25.64 k | 8.51 k shares | 0.62 | Common equity | Long | UK |
NTRA Natera, Inc. | 24.57 k | 240.00 shares | 0.59 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 24.13 k | 990.00 shares | 0.58 | Common equity | Long | USA |
ICON PLC
|
23.65 k | 72.00 shares | 0.57 | Common equity | Long | Ireland |
STERIS PLC
|
23.40 k | 98.00 shares | 0.56 | Common equity | Long | Ireland |
VRTX Vertex Pharmaceuticals Incorporated | 22.80 k | 46.00 shares | 0.55 | Common equity | Long | USA |
BDX Becton, Dickinson and Company | 21.70 k | 90.00 shares | 0.52 | Common equity | Long | USA |
PEN Penumbra, Inc. | 21.55 k | 129.00 shares | 0.52 | Common equity | Long | USA |
CTLT Catalent, Inc. | 21.48 k | 362.00 shares | 0.52 | Common equity | Long | USA |
Roivant Sciences Ltd
|
20.59 k | 1.90 k shares | 0.49 | Common equity | Long | Bermuda |
HALO Halozyme Therapeutics, Inc. | 19.56 k | 354.00 shares | 0.47 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 19.34 k | 884.00 shares | 0.46 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 19.33 k | 611.00 shares | 0.46 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 18.55 k | 164.00 shares | 0.45 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 18.32 k | 427.00 shares | 0.44 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 17.95 k | 363.00 shares | 0.43 | Common equity | Long | USA |
EHC Encompass Health Corporation | 17.47 k | 188.00 shares | 0.42 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 16.89 k | 698.00 shares | 0.41 | Common equity | Long | USA |
STOK Stoke Therapeutics, Inc. | 16.83 k | 1.12 k shares | 0.40 | Common equity | Long | USA |
Genmab A/S
|
16.38 k | 58.00 shares | 0.39 | Common equity | Long | Denmark |
INCY Incyte Corporation | 16.27 k | 250.00 shares | 0.39 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 16.21 k | 479.00 shares | 0.39 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 16.02 k | 287.00 shares | 0.38 | Common equity | Long | USA |
Roche Holding AG
|
15.86 k | 49.00 shares | 0.38 | Common equity | Long | Switzerland |
TCRX TScan Therapeutics, Inc. | 15.62 k | 2.19 k shares | 0.38 | Common equity | Long | USA |
CNMD CONMED Corporation | 14.08 k | 204.00 shares | 0.34 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 13.18 k | 479.00 shares | 0.32 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 11.99 k | 263.00 shares | 0.29 | Common equity | Long | USA |
Helix Acquisition Corp II
|
11.78 k | 1.14 k shares | 0.28 | Common equity | Long | Cayman Islands |
EXAS Exact Sciences Corporation | 11.37 k | 249.00 shares | 0.27 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 11.26 k | 250.00 shares | 0.27 | Common equity | Long | USA |
BDTX Black Diamond Therapeutics, Inc. | 11.17 k | 1.83 k shares | 0.27 | Common equity | Long | USA |
Alkermes PLC
|
10.90 k | 399.00 shares | 0.26 | Common equity | Long | Ireland |
GKOS Glaukos Corporation | 10.66 k | 91.00 shares | 0.26 | Common equity | Long | USA |
TNDM Tandem Diabetes Care, Inc. | 10.65 k | 288.00 shares | 0.26 | Common equity | Long | USA |
SLNO Soleno Therapeutics, Inc. | 10.56 k | 219.00 shares | 0.25 | Common equity | Long | USA |
TXG 10x Genomics, Inc. | 10.50 k | 508.00 shares | 0.25 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 10.02 k | 386.00 shares | 0.24 | Common equity | Long | USA |
MLTX MoonLake Immunotherapeutics | 9.87 k | 237.00 shares | 0.24 | Common equity | Long | Cayman Islands |
Biohaven Ltd
|
9.36 k | 238.00 shares | 0.22 | Common equity | Long | Virgin Islands (British) |
MORF Morphic Holding, Inc. | 9.18 k | 162.00 shares | 0.22 | Common equity | Long | USA |
Novocure Ltd
|
9.15 k | 402.00 shares | 0.22 | Common equity | Long | Jersey |
DXCM DexCom, Inc. | 9.02 k | 133.00 shares | 0.22 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 8.73 k | 174.00 shares | 0.21 | Common equity | Long | USA |
RDNT RadNet, Inc. | 8.48 k | 142.00 shares | 0.20 | Common equity | Long | USA |
Galapagos NV
|
8.24 k | 309.00 shares | 0.20 | Common equity | Long | Belgium |
AUTL Autolus Therapeutics plc | 8.11 k | 1.73 k shares | 0.19 | Common equity | Long | UK |
TARS Tarsus Pharmaceuticals, Inc. | 8.09 k | 333.00 shares | 0.19 | Common equity | Long | USA |
Nyxoah SA
|
8.01 k | 946.00 shares | 0.19 | Common equity | Long | Belgium |
CABA Cabaletta Bio, Inc. | 7.87 k | 1.11 k shares | 0.19 | Common equity | Long | USA |
VYGR Voyager Therapeutics, Inc. | 7.16 k | 779.00 shares | 0.17 | Common equity | Long | USA |
Immatics NV
|
6.85 k | 570.00 shares | 0.16 | Common equity | Long | Netherlands |
AC Immune SA
|
6.82 k | 1.67 k shares | 0.16 | Common equity | Long | Switzerland |
AXSM Axsome Therapeutics, Inc. | 6.55 k | 75.00 shares | 0.16 | Common equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 5.91 k | 540.00 shares | 0.14 | Common equity | Long | USA |
LNTH Lantheus Holdings, Inc. | 5.89 k | 433.00 shares | 0.14 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 5.70 k | 509.00 shares | 0.14 | Common equity | Long | USA |
RCUS Arcus Biosciences, Inc. | 5.66 k | 345.00 shares | 0.14 | Common equity | Long | USA |
Genmab A/S
|
5.35 k | 189.00 shares | 0.13 | Common equity | Long | Denmark |
GPCR Structure Therapeutics Inc. | 5.31 k | 142.00 shares | 0.13 | Common equity | Long | Cayman Islands |
Arcturus Therapeutics Holdings, Inc. | 5.30 k | 226.00 shares | 0.13 | Common equity | Long | USA |
VKTX Viking Therapeutics, Inc. | 5.30 k | 93.00 shares | 0.13 | Common equity | Long | USA |
BCYC Bicycle Therapeutics plc | 4.96 k | 204.00 shares | 0.12 | Common equity | Long | UK |
ARWR Arrowhead Pharmaceuticals, Inc. | 4.77 k | 167.00 shares | 0.11 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 4.55 k | 1.55 k shares | 0.11 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 4.47 k | 113.00 shares | 0.11 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 4.27 k | 128.00 shares | 0.10 | Common equity | Long | USA |
PRME Prime Medicine, Inc. | 4.21 k | 751.00 shares | 0.10 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics, Inc. | 4.17 k | 235.00 shares | 0.10 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 3.33 k | 234.00 shares | 0.08 | Common equity | Long | USA |
SGMT Sagimet Biosciences Inc. | 2.91 k | 867.00 shares | 0.07 | Common equity | Long | USA |
NMRA Neumora Therapeutics, Inc. Common Stock | 2.80 k | 218.00 shares | 0.07 | Common equity | Long | USA |
NUVB Nuvation Bio Inc. | 2.75 k | 718.00 shares | 0.07 | Common equity | Long | USA |
TNYA Tenaya Therapeutics, Inc. | 2.18 k | 623.00 shares | 0.05 | Common equity | Long | USA |
LBPH Longboard Pharmaceuticals, Inc. | 2.09 k | 63.00 shares | 0.05 | Common equity | Long | USA |
VIGL Vigil Neuroscience, Inc. | 1.98 k | 475.00 shares | 0.05 | Common equity | Long | USA |
BMEA Biomea Fusion, Inc. | 1.70 k | 305.00 shares | 0.04 | Common equity | Long | USA |
MGNX MacroGenics, Inc. | 1.45 k | 386.00 shares | 0.03 | Common equity | Long | USA |
KYTX Kyverna Therapeutics, Inc. | 1.10 k | 127.00 shares | 0.03 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics, Inc. | 1.04 k | 230.00 shares | 0.02 | Common equity | Long | USA |
LXEO Lexeo Therapeutics, Inc. Common Stock | 753.00 | 60.00 shares | 0.02 | Common equity | Long | USA |
CONTRA ABIOMED INC | 398.52 | 246.00 shares | 0.01 | Long | USA | |
CONTRA MIRATI THERAPEU | 237.14 | 334.00 shares | 0.01 | Long | USA | |
CONTRA FREQUENCY THERA | 0 | 420.00 shares | 0.00 | Long | USA |